781 related articles for article (PubMed ID: 22608531)
1. Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis.
Liao CH; Chi CY; Wang YJ; Tseng SW; Chou CH; Ho CM; Lin PC; Ho MW; Wang JH
J Microbiol Immunol Infect; 2012 Aug; 45(4):296-304. PubMed ID: 22608531
[TBL] [Abstract][Full Text] [Related]
2. 'Time-to-amphotericin B' in cryptococcal meningitis in a European low-prevalence setting: analysis of diagnostic delays.
Katchanov J; von Kleist M; Arastéh K; Stocker H
QJM; 2014 Oct; 107(10):799-803. PubMed ID: 24722846
[TBL] [Abstract][Full Text] [Related]
3. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures.
Bicanic T; Brouwer AE; Meintjes G; Rebe K; Limmathurotsakul D; Chierakul W; Teparrakkul P; Loyse A; White NJ; Wood R; Jaffar S; Harrison T
AIDS; 2009 Mar; 23(6):701-6. PubMed ID: 19279443
[TBL] [Abstract][Full Text] [Related]
4. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S
J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
[TBL] [Abstract][Full Text] [Related]
5. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.
Brouwer AE; Rajanuwong A; Chierakul W; Griffin GE; Larsen RA; White NJ; Harrison TS
Lancet; 2004 May; 363(9423):1764-7. PubMed ID: 15172774
[TBL] [Abstract][Full Text] [Related]
6. Comparisons of presentations and outcomes of cryptococcal meningitis between patients with and without hepatitis B virus infection.
Zhong YH; Tan F; Li M; Liu J; Wang X; Yuan Y; Zhong XF; Peng FH
Int J Infect Dis; 2014 Mar; 20():31-6. PubMed ID: 24440644
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B.
Pitisuttithum P; Tansuphasawadikul S; Simpson AJ; Howe PA; White NJ
J Infect; 2001 Nov; 43(4):226-33. PubMed ID: 11869059
[TBL] [Abstract][Full Text] [Related]
8. Early mycological treatment failure in AIDS-associated cryptococcal meningitis.
Robinson PA; Bauer M; Leal MA; Evans SG; Holtom PD; Diamond DA; Leedom JM; Larsen RA
Clin Infect Dis; 1999 Jan; 28(1):82-92. PubMed ID: 10028076
[TBL] [Abstract][Full Text] [Related]
9. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
[TBL] [Abstract][Full Text] [Related]
10. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
Sloan D; Dlamini S; Paul N; Dedicoat M
Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
[TBL] [Abstract][Full Text] [Related]
11. A retrospective study of AIDS-associated cryptomeningitis.
Sachdeva RK; Randev S; Sharma A; Wanchu A; Chakrabarti A; Singh S; Varma S
AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1220-6. PubMed ID: 22369456
[TBL] [Abstract][Full Text] [Related]
12. Comparisons of clinical features and mortality of cryptococcal meningitis between patients with and without human immunodeficiency virus infection.
Lee YC; Wang JT; Sun HY; Chen YC
J Microbiol Immunol Infect; 2011 Oct; 44(5):338-45. PubMed ID: 21524972
[TBL] [Abstract][Full Text] [Related]
13. Current approach to the acute management of cryptococcal infections.
Powderly WG
J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709
[No Abstract] [Full Text] [Related]
14. [Disseminated cryptococcosis in patients with AIDS. Clinical, microbiological, and immunological analysis of 51 patients].
Metta HA; Corti ME; Negroni R; Helou S; Arechavala A; Soto I; Villafañe MF; Muzzio E; Castello T; Esquivel P; Trione N
Rev Argent Microbiol; 2002; 34(3):117-23. PubMed ID: 12415893
[TBL] [Abstract][Full Text] [Related]
15. Preventing deaths from cryptococcal meningitis: from bench to bedside.
Roy M; Chiller T
Expert Rev Anti Infect Ther; 2011 Sep; 9(9):715-7. PubMed ID: 21905781
[TBL] [Abstract][Full Text] [Related]
16. The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension without ventriculomegally secondary to HIV-associated cryptococcal meningitis.
Woodworth GF; McGirt MJ; Williams MA; Rigamonti D
Surg Neurol; 2005 Jun; 63(6):529-31; discussion 531-2. PubMed ID: 15936373
[TBL] [Abstract][Full Text] [Related]
17. Triple therapy combined with ventriculoperitoneal shunts can improve neurological function and shorten hospitalization time in non-HIV cryptococcal meningitis patients with increased intracranial pressure.
Li M; Liu J; Deng X; Gan Q; Wang Y; Xu X; Jiang Y; Peng F
BMC Infect Dis; 2020 Nov; 20(1):844. PubMed ID: 33198666
[TBL] [Abstract][Full Text] [Related]
18. Recurrence of cryptococcal meningitis in HIV-infected patients following immune reconstitution.
Seddon J; Mangeya N; Miller RF; Corbett EL; Ferrand RA
Int J STD AIDS; 2009 Apr; 20(4):274-5. PubMed ID: 19304977
[TBL] [Abstract][Full Text] [Related]
19. Cryptococcal meningitis in HIV-infected patients.
Leenders AC; van der Ende ME; van der Ree TC; de Marie S
AIDS; 1994 Dec; 8(12):1741-3. PubMed ID: 7888131
[No Abstract] [Full Text] [Related]
20. Changing paradigm of cryptococcal meningitis: an eight-year experience from a tertiary hospital in South India.
Abhilash KP; Mitra S; Arul JJ; Raj PM; Balaji V; Kannangai R; Thomas SA; Abraham OC
Indian J Med Microbiol; 2015; 33(1):25-9. PubMed ID: 25559998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
